What is the treatment for persistent hiccups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Persistent Hiccups

For persistent hiccups (lasting >48 hours), chlorpromazine 25-50 mg orally three to four times daily is the FDA-approved first-line pharmacological treatment, with metoclopramide as a second-line alternative if chlorpromazine fails or is contraindicated. 1, 2

Initial Assessment and Risk Stratification

Before initiating treatment, monitor patients approaching 48 hours of hiccups for signs of respiratory compromise, particularly those with pre-existing respiratory conditions, as severe cases can lead to laryngospasm and post-obstructive pulmonary edema. 3

Be aware that untreated persistent hiccups can result in weight loss and depression, making prompt treatment important for quality of life. 4

Pharmacological Treatment Algorithm

First-Line: Chlorpromazine

Chlorpromazine is the only FDA-approved medication specifically indicated for intractable hiccups. 1, 2

Dosing:

  • Oral: 25-50 mg three to four times daily 1
  • If symptoms persist for 2-3 days on oral therapy, consider intramuscular administration: 25-50 mg IM 2
  • For severe refractory cases: 25-50 mg in 500-1000 mL saline by slow IV infusion with patient supine, monitoring blood pressure closely 2

Critical Safety Considerations:

  • Chlorpromazine causes hypotension, sedation, extrapyramidal symptoms, and QT interval prolongation 4
  • Keep patients lying down for at least 30 minutes after parenteral administration due to hypotensive effects 2
  • Use lower doses in elderly, debilitated, or emaciated patients who are more susceptible to hypotension and neuromuscular reactions 1, 2

Second-Line: Metoclopramide

If chlorpromazine is ineffective or contraindicated, the American Society of Clinical Oncology recommends metoclopramide as a second-line agent based on randomized controlled trial evidence. 4 The National Comprehensive Cancer Network also supports metoclopramide as an alternative treatment. 4

Metoclopramide is particularly recommended as first-choice for peripheral causes of hiccups (versus central causes). 5

Etiology-Based Approach

Gastroesophageal Reflux Disease (Most Common Cause)

GERD is the most common cause of persistent hiccups, making proton pump inhibitor (PPI) therapy with appropriate gastroenterology consultation the recommended first-line approach when GERD is suspected. 6

  • Initiate high-dose PPI therapy 7
  • Response time is variable: some patients respond within 2 weeks, others may require several months 7
  • If partial or no improvement occurs, add prokinetic therapy (such as metoclopramide) 7
  • Consider 24-hour esophageal pH monitoring if symptoms persist despite empiric therapy 7

Central Nervous System Causes

For central causes (stroke, brain tumors, traumatic brain injury), baclofen is the drug of choice rather than metoclopramide. 4, 5

Non-Pharmacological Interventions

Physical Maneuvers

Simple measures that stimulate the uvula/pharynx or disrupt diaphragmatic rhythm should be attempted first for self-limited hiccups, as they may also terminate persistent episodes. 8

Interventional Procedures

For medication-refractory cases, consider:

  • Vagal or phrenic nerve block or stimulation 5
  • Phrenic nerve pacing 9
  • Acupuncture (though evidence quality is limited) 10

Evidence Quality and Limitations

A critical caveat: Despite widespread clinical use of pharmacological agents, a 2013 Cochrane review found insufficient high-quality evidence to definitively guide treatment of persistent or intractable hiccups. 10 No randomized placebo-controlled trials of pharmacological interventions met their inclusion criteria. 10 The chlorpromazine recommendation is based primarily on FDA approval and decades of clinical experience rather than robust controlled trial data. 1, 2, 8

The relative rarity of persistent hiccups makes conducting adequately powered trials challenging, necessitating multi-center or multi-national collaboration for future research. 10

Clinical Pitfalls to Avoid

  • Do not use subcutaneous injection of chlorpromazine 2
  • Avoid injecting undiluted chlorpromazine directly into veins; IV route is reserved only for severe hiccups, surgery, and tetanus 2
  • Avoid contact of chlorpromazine solution with skin or clothing due to contact dermatitis risk 2
  • Do not assume all persistent hiccups are benign—they may indicate serious underlying pathology requiring investigation 6
  • If PPI therapy for presumed GERD fails, explore other etiologies including central nervous system causes rather than continuing ineffective treatment 7, 6

References

Guideline

Hiccups Management and Clinical Concerns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hiccups Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of hiccups in palliative care patients.

BMJ supportive & palliative care, 2018

Research

Chronic Hiccups.

Current treatment options in gastroenterology, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hiccups: causes and cures.

Journal of clinical gastroenterology, 1985

Research

Hiccup: mystery, nature and treatment.

Journal of neurogastroenterology and motility, 2012

Research

Interventions for treating persistent and intractable hiccups in adults.

The Cochrane database of systematic reviews, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.